989 / 1084
PS 0–1
compared with PS 2 and
locally advanced disease
compared with metastatic disease were
significant predictors of improved OS
Progression of disease during first-line treatment or within the first 3 months of completion of
first-line
treatment were
predictors of an increased risk of death
compared with progression between
3 and 6 months
03/28/2017